IRONWOOD PHARMACEUTICALS INC

Q3 2024 13F holders

CUSIP
46333XAH1
Type
Debt
Class
NOTE 1.500% 6/1
Total Reported Value ($000, excl. options)
Manager Report date Value ($000) Principal Option type